Prostate cancer therapy not tied to bladder cancer
Key points
- There's good news for men who have undergone therapy with focused radiation beams for Prostate cancer.
- Previous reports have suggested that, in women, using radiation therapy for gynecologic cancers at least doubles the risk of Bladder cancer, say researchers in The Journal of Urology.
- Bradley Leibovich and colleagues, from the Mayo Clinic in Rochester, Minnesota, analyzed data from 1743 patients who underwent radiation for Prostate cancer at their center between 1980 and 1998.
- After several years of follow-up, Prostate cancer radiation was not tied to an elevated risk of Bladder cancer, the investigators report.
There's good news for men who have undergone therapy with focused radiation beams for Prostate cancer. The common treatment does not raise the risk of developing Bladder cancer, according to a new study.
Previous reports have suggested that, in women, using radiation therapy for gynecologic cancers at least doubles the risk of Bladder cancer, say researchers in The Journal of Urology. However, it is unclear if radiation therapy for Prostate cancer also has this effect.
To investigate, Dr. Bradley Leibovich and colleagues, from the Mayo Clinic in Rochester, Minnesota, analyzed data from 1743 patients who underwent radiation for Prostate cancer at their center between 1980 and 1998.
After several years of follow-up, Prostate cancer radiation was not tied to an elevated risk of Bladder cancer, the investigators report.
"The natural history of Bladder cancer in this population does not seem to be altered by radiation," they add, "except that some patients seem to be diagnosed earlier."
SOURCE: The Journal of Urology, July 2005.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsProstate cancer may respond to more hormone therapy
Suppression of the male hormone androgen in locally advanced prostate cancer appears to be more successful when treatment is prolonged, according to Canadian and US researchers. In a March 23rd online paper issued by…
16 April 2009
NewsProstate cancer anxiety may affect therapy choices
Among men who have been treated for prostate cancer, those who are particularly anxious after signs of a recurrence may not make the best decision about the next step in treatment, new research shows. Specifically,…
5 March 2009
NewsTest monitors prostate cancer chemotherapy effects
A test that looks for tumor cells in the blood may make doctors better able to check whether chemotherapy is helping a prostate cancer patient, researchers reported on Tuesday. The CellSearch test, made by Johnson &…
